Literature DB >> 11583628

The TGF beta receptor activation process: an inhibitor- to substrate-binding switch.

M Huse1, T W Muir, L Xu, Y G Chen, J Kuriyan, J Massagué.   

Abstract

The type I TGF beta receptor (T beta R-I) is activated by phosphorylation of the GS region, a conserved juxtamembrane segment located just N-terminal to the kinase domain. We have studied the molecular mechanism of receptor activation using a homogeneously tetraphosphorylated form of T beta R-I, prepared using protein semisynthesis. Phosphorylation of the GS region dramatically enhances the specificity of T beta R-I for the critical C-terminal serines of Smad2. In addition, tetraphosphorylated T beta R-I is bound specifically by Smad2 in a phosphorylation-dependent manner and is no longer recognized by the inhibitory protein FKBP12. Thus, phosphorylation activates T beta R-I by switching the GS region from a binding site for an inhibitor into a binding surface for substrate. Our observations suggest that phosphoserine/phosphothreonine-dependent localization is a key feature of the T beta R-I/Smad activation process.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11583628     DOI: 10.1016/s1097-2765(01)00332-x

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  121 in total

1.  NMR structure of the forkhead-associated domain from the Arabidopsis receptor kinase-associated protein phosphatase.

Authors:  Gui-In Lee; Zhaofeng Ding; John C Walker; Steven R Van Doren
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-18       Impact factor: 11.205

2.  Coated pit-mediated endocytosis of the type I transforming growth factor-β (TGF-β) receptor depends on a di-leucine family signal and is not required for signaling.

Authors:  Keren E Shapira; Avner Gross; Marcelo Ehrlich; Yoav I Henis
Journal:  J Biol Chem       Date:  2012-06-15       Impact factor: 5.157

3.  Peptide ligands that use a novel binding site to target both TGF-β receptors.

Authors:  Lingyin Li; Brendan P Orner; Tao Huang; Andrew P Hinck; Laura L Kiessling
Journal:  Mol Biosyst       Date:  2010-10-04

Review 4.  Chemical synthesis of proteins.

Authors:  Bradley L Nilsson; Matthew B Soellner; Ronald T Raines
Journal:  Annu Rev Biophys Biomol Struct       Date:  2005

5.  2005 Irving Sigal Young Investigator Award.

Authors:  Tom W Muir
Journal:  Protein Sci       Date:  2005-12       Impact factor: 6.725

6.  PhosphoThr peptide binding globally rigidifies much of the FHA domain from Arabidopsis receptor kinase-associated protein phosphatase.

Authors:  Zhaofeng Ding; Gui-in Lee; Xiangyang Liang; Fabio Gallazzi; A Arunima; Steven R Van Doren
Journal:  Biochemistry       Date:  2005-08-02       Impact factor: 3.162

7.  The immunophilin FKBP12 inhibits hepcidin expression by binding the BMP type I receptor ALK2 in hepatocytes.

Authors:  Silvia Colucci; Alessia Pagani; Mariateresa Pettinato; Irene Artuso; Antonella Nai; Clara Camaschella; Laura Silvestri
Journal:  Blood       Date:  2017-09-01       Impact factor: 22.113

8.  Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia.

Authors:  R E Harrison; J A Flanagan; M Sankelo; S A Abdalla; J Rowell; R D Machado; C G Elliott; I M Robbins; H Olschewski; V McLaughlin; E Gruenig; F Kermeen; M Halme; A Räisänen-Sokolowski; T Laitinen; N W Morrell; R C Trembath
Journal:  J Med Genet       Date:  2003-12       Impact factor: 6.318

Review 9.  Functional diversity and pharmacological profiles of the FKBPs and their complexes with small natural ligands.

Authors:  Andrzej Galat
Journal:  Cell Mol Life Sci       Date:  2012-12-08       Impact factor: 9.261

10.  Antagonistic Smad transcription factors control the dauer/non-dauer switch in C. elegans.

Authors:  Donha Park; Annette Estevez; Donald L Riddle
Journal:  Development       Date:  2010-02       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.